BioSpace News Archive

Breakthroughs in quantum computing will enable humans to cure diseases like cancer, Alzheimer’s, and Parkinson’s as easily as we treat the common cold.

Todos Medical, an in-vitro diagnostics company that develops reliable early-detection blood tests and related solutions for cancer, neurodegenerative disorders, and coronaviruses, announced the advancement of its Tollovir™ clinical trials for hospitalized COVID-19 patients.

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced publication in the Cell Press journal Med of data detailing work relating to the discovery and preclinical profiling of STI-9167 neutralizing antibody activity against a broad collection of SARS-CoV-2 variants, including select Omicron subvariants.

Passage Bio, Inc. announced it has granted inducement awards to its newly appointed chief executive officer, William Chou, M.D.

Syneos Health®, the only fully integrated biopharmaceutical solutions organization, announced the appointment of William E. Klitgaard to its Board of Directors.

Zambon announced that the Company will present findings examining how Chronic Lung Allograft Dysfunction is the leading cause of re-transplantation and associated with high healthcare costs during a rapid oral session at the American College of Chest Physicians® 2022 Annual Meeting being held October 16 – 19, 2022 in Nashville, TN.

A new study recently published in the journal Annals of Internal Medicine, written by The Feinstein Institutes for Medical Research’s Karina Davidson, PhD, reviews preventative lung cancer screening guidelines and outlines hurdles health systems and clinicians still need to overcome to make prevention more effective – including the need for follow-up care.

ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that the Company will present five posters on REACT and CKD at the upcoming American Society of Nephrology’s (ASN) Kidney Week being held November 3-6, 2022, in Orlando, FL.

Sintetica, a Swiss pharmaceutical company headquartered in Mendrisio specializing in injectables in the field of pain therapy, has taken another important and significant step in its 100-year growth strategy.

DaVita Inc., announced that it will hold its quarterly conference call to discuss third quarter results on Friday, October 28, 2022, at 8:30 a.m. Eastern Time.